Results 111 to 120 of about 257,914 (221)

Twenty Years of Therapeutic Leukocytapheresis in Newly Diagnosed Acute Myeloid Leukemia: Insights From A Single Center

open access: yesJournal of Clinical Apheresis, Volume 41, Issue 2, April 2026.
ABSTRACT Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy, and 5%–20% of newly diagnosed patients present with hyperleukocytosis (HL). HL, most often defined as WBC > 100 000/μL, is a hematologic emergency associated with severe complications, early mortality, and poor prognosis, requiring immediate intervention.
Vojtech Latal   +10 more
wiley   +1 more source

Multiday Use of Non‐Tunneled Central Venous Catheters in Vetted Adult Outpatients Undergoing Apheresis Collections of Autologous Peripheral Blood Stem Cells Is Feasible and Well Tolerated

open access: yesJournal of Clinical Apheresis, Volume 41, Issue 2, April 2026.
ABSTRACT Autologous peripheral blood stem cell (PBSC) collections are routinely performed in the outpatient setting and typically involve placement of an apheresis‐compatible central venous catheter (CVC). There is reluctance to discharge outpatients with non‐tunneled CVCs due to safety concerns.
Andres E. Mindiola Romero   +4 more
wiley   +1 more source

Transcriptomic biomarkers of altered erythropoiesis to detect autologous blood transfusion.

open access: yesDrug Testing and Analysis, 2018
O. Salamin   +4 more
semanticscholar   +1 more source

Repeated injection of pooled frozen allogeneic umbilical cord blood mesenchymal stromal cells in 5 flat‐racing horses

open access: yesEquine Veterinary Education, Volume 38, Issue 4, Page 183-194, April 2026.
Summary Background Tendinopathies in racehorses are challenging to treat, and restoring normal tendon composition remains elusive despite extensive research. Equine multipotent mesenchymal stromal cells (MSC) have shown promise for tendon repair, and various sources of MSC have been described.
A. Merchan Muñoz   +7 more
wiley   +1 more source

Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis. [PDF]

open access: yesBone Marrow Transplant, 2021
Farhadfar N   +36 more
europepmc   +1 more source

Molecular Testing in Sickle Cell Disease: From Newborn Screening to Transfusion Care

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 2, Page 295-304, April 2026.
ABSTRACT Sickle cell disease (SCD) is one of the most frequent monogenic diseases worldwide and a highly heterogeneous and complex disease. SCD care carries several challenges. This includes early and accurate diagnosis as well as optimal red blood cell transfusion matching in this population carrying a high risk of alloimmunization.
Thomas Pincez, Yves D. Pastore
wiley   +1 more source

Research Progress on Platelet‐Rich Plasma (PRP) in the Treatment of Androgenetic Alopecia

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 4, April 2026.
ABSTRACT Background Androgenetic alopecia (AGA) is the most common cause of progressive hair loss, significantly affecting quality of life. Current therapies, such as minoxidil, finasteride, and hair transplantation, show variable efficacy and may be associated with adverse effects.
Zetian Zhong   +4 more
wiley   +1 more source

[Clinical effects of medical ozone autologous blood transfusion combined with Xingnaojing in the treatment of septic encephalopathy in burns]. [PDF]

open access: yesZhonghua Shao Shang Za Zhi, 2021
Ye XY   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy